Canatu receives a purchase order for semiconductor inspection membranes
Canatu Plc (CANATU, Nasdaq First North, Finland) has received a purchase order from a leading, existing semiconductor industry customer to supply inspection membranes used in Extreme Ultraviolet (EUV) mask inspection. The use of these membranes reduces damage to EUV optics and enhances quality control during EUV mask inspection.
The value of the purchase order for Canatu’s CNT products is classified within the lowest quartile of the “medium” category (EUR 1.0–5.0 million) outlined in Canatu’s disclosure policy. Revenue from the order will be fully recognized in the 2025 financial year.
“We are proud to strengthen our long-standing relationship with this key customer. Since 2021, Canatu has mass-produced inspection membranes, underlining our commitment to delivering reliable, high-quality solutions that support critical quality control in the semiconductor industry.”
Juha Kokkonen, CEO, Canatu Plc
Today, Canatu is a leading supplier of inspection membranes for EUV mask inspection. Beyond this application, Canatu inspection membranes have potential for other quality control phases within EUV processes.
Additional information
CEO Juha Kokkonen, tel. +358 405 430 367
Board member Tuomo Vähäpassi, tuomo.vahapassi@lifeline-spac1.com
Certified adviser
DNB Carnegie Investment Bank AB (publ), tel. +46 (0)73 856 42 65
About Canatu
Canatu (CANATU, Nasdaq First North, Finland) is a fast-growing deep technology company creating advanced carbon nanotubes (Canatu CNTs), related products, and manufacturing equipment for the semiconductor, automotive, and medical diagnostics industries. Canatu partners with forerunner companies, together transforming products for better tomorrows with nano carbon.
Canatu’s versatile platform technology has broad potential applications. Its current core includes CNT membranes for extreme ultraviolet (EUV) processes in the semiconductor industry, enabling the manufacturing of the most advanced chips, as well as film heaters for advanced driver-assistance systems (ADAS) in the automotive industry. Additionally, electrochemical sensors for medical diagnostics are in the development phase. Canatu’s patented CNT reactors and Dry DepositionTM method yield clean and pristine CNTs. The company operates through two business models: selling CNT products directly, as well as selling CNT reactors and licensing the related technology so that customers can produce CNT products under a limited license.
Headquartered in Finland, Canatu also operates in the US, Japan, and Taiwan. Founded in 2004 as a spin-off from Aalto University’s Nanomaterials Group, Canatu currently has around 140 employees representing 35 nationalities, with 20 percent holding or pursuing doctorates. Discover more at www.canatu.com and follow us on LinkedIn.
Media relations
